12:00 AM
Feb 04, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

D&A Pharma, Imaxio sales and marketing update

D&A granted Imaxio rights to congenital metabolic disease drug Trolovol d-penicillamine in France. The chelator is marketed in...

Read the full 66 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >